C39 - How to Design Meaningful Clinical Trials
| Event Time: | Sunday May 5, 2019 7:00 am to 9:00 am |
| Topic(s): | Research Methodology, Education, and History, Academic, Futures In Neurological Research |
| Director(s): | Laurie Gutmann MD, FAAN |
| Description: | Clinical research design methodology is important not only to the development of a clinical trial but also in understanding the results of a reported clinical trial. Major flaws in trial design include: designing a phase 2 trial that does not lead to a stronger phase 3 trial, choosing outcome or endpoint measures that either do not answer the question being raised by the trial or do not inform the next step in the study, or designing the phase 2 trial as an underpowered phase 3 trial. This program will review trial design for early phase trials and review examples motivated from experience gained as part of the NINDS-funded clinical trials methods training course that aim to avoid these pitfalls. A panel will then discuss how to design a trial based on examples and clinical trial questions received from the audience. |
| Completion Message: | Participants should have a better understanding of how to design a clinical trial, how to choose a appropriate design and interpret validity of findings from a clinical trial, as well as the importance of endpoint measures. |
| CME Credits: | 2 |
| Core Competencies: | Medical Knowledge, Practice-Based Learning and Improvement |
| Start/End Time | Title | Faculty |
|---|---|---|
| 7:00 AM - 7:40 AM | Introduction to Meaningful Clinical Trial Design: Pitfalls and Pearls | Christopher Coffey PhD |
| 7:40 AM - 8:20 AM | Endpoint Selection and Outcome Measures | William Joseph Meurer MD |
| 8:20 AM - 9:00 AM | Building a Trial – An Interactive Exercise | Christopher Coffey PhD, Robin A. Conwit MD, FAAN, Laurie Gutmann MD, FAAN, William Joseph Meurer MD |
| Speaker | Disclosure |
|---|---|
| Christopher Coffey, PhD | Dr. Coffey has nothing to disclose. |
| Robin A. Conwit, MD, FAAN | Dr. Conwit has nothing to disclose. |
| Laurie Gutmann, MD, FAAN | Dr. Gutmann has received research support from Alexion Pharmaceuticals. |
| William Joseph Meurer, MD | Dr. Meurer has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with various law firms, regarding medicolegal cases. Dr. Meurer has received personal compensation in an editorial capacity for Trials and Academic Emergency Medicine Journal. |
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
| 7:00 AM-7:30 AM |
|---|
|
Grant Writing 101: Getting Started
Logan Schneider MD |
|
Trainee Experience: Navigating the AAN and Your Career
|
| 7:00 AM-9:00 AM |
|
C249 -
Clinical Pearls: Learning from Complex Cases Simple Lessons that Apply to Everyday Problems
S. Josephson MD, FAAN |
| 8:00 AM-8:30 AM |
|
How to Put Together Effective Research Presentations
Enrique Leira MD, MS, FAAN |
| 8:00 AM-8:45 AM |
|
How to Give Effective Feedback
Adnan Subei DO, Diana Barratt MD, MPH, FAAN, Maryam Shakir MPH, Jill Liebman DO, Farah Fourcand MD |
| 1:00 PM-1:45 PM |
|
Growing Research in Medical Marijuana
Anup Patel MD, FAAN |
|
K is for Career Development: Tips on Successful Applications for NIH Career Development Awards
Logan Schneider MD |
| 3:00 PM-3:45 PM |
|
Sleep: Why You Should Spend Your Career Helping People Do It Right
Logan Schneider MD |